SBFM 04-09-2012 is pleased to announce that it has recently received notification that the United States Patent and Trademark Office has issued a “Notice of Allowance” for the patent application covering its lead anti-tumor compound, Adva-27a. http://ih.advfn.com/p.php?pid=nmona&article=51936483